Kepos Capital’s Johnson & Johnson JNJ Stock Holding History

Kepos Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-202	Closed	-$33K	–	134
2024 Q3	$33K	Sell	202 -47	-19%	-$7.49K	0.01%	178
2024 Q2	$36K	Sell	249 -22	-8%	-$3.27K	0.01%	180
2024 Q1	$43K	Sell	271 -2	-0.7%	-$318	0.01%	195
2023 Q4	$43K	Sell	273 -13	-5%	-$1.99K	0.01%	159
2023 Q3	$45K	Buy	286 +30	+12%	+$4.95K	0.01%	178
2023 Q2	$42K	Buy	+256	New	+$41.3K	0.01%	232
2022 Q4	$45K	Buy	+254	New	+$43.9K	0.01%	250
2019 Q4	–	Sell	-3,141	Closed	-$406K	–	386
2019 Q3	$406K	Buy	+3,141	New	+$414K	0.04%	222
2019 Q2	–	Sell	-18,517	Closed	-$2.59M	–	361
2019 Q1	$2.59M	Sell	18,517 -32,556	-64%	-$4.36M	0.19%	141
2018 Q4	$6.59M	Buy	51,073 +2,464	+5%	+$344K	0.51%	36
2018 Q3	$6.72M	Sell	48,609 -407	-0.8%	-$54.1K	0.34%	49
2018 Q2	$5.95M	Buy	49,016 +10,021	+26%	+$1.25M	0.3%	73
2018 Q1	$5M	Buy	+38,995	New	+$5.27M	0.29%	64
2017 Q4	–	Sell	-7,879	Closed	-$1.02M	–	184
2017 Q3	$1.02M	Buy	+7,879	New	+$1.04M	0.17%	55

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kepos Capital's JNJ Position: Q4 2024 in Review

Kepos Capital sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 202 shares — an estimated $33K sold.

Kepos Capital first reported a position in JNJ in Q3 2017 and held it in 14 quarters. The position peaked at $6.72M in Q3 2018. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

Kepos Capital reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
Kepos Capital sold 202 Johnson & Johnson shares in Q4 2024, an estimated $33K.
Kepos Capital first reported a position in Johnson & Johnson in Q3 2017 and held it in 14 quarters.
Kepos Capital's Johnson & Johnson position peaked at $6.72M in Q3 2018.
4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Kepos Capital's 13F filing for Q4 2024, filed 11 Feb 2025.